SUMMIT, N.J., June 20 /PRNewswire-FirstCall/ -- Celgene Corporation announced today that its presentation at the NASDAQ 17th Investor Program on Wednesday, June 21, 2006 at 8:30 am BST will be webcast live and will be available in the investor relations section of the Company’s website at http://www.celgene.com . Celgene senior management will provide an overview of the company.
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the Company’s website at http://www.celgene.com .
This release contains forward-looking statements which are subject to known and unknown risks, delays, uncertainties and other factors not under the Company’s control, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. These factors include results of current or pending research and development activities, actions by the FDA and other regulatory authorities, and other factors described in the Company’s filings with the Securities and Exchange Commission such as our 10K, 10Q and 8K reports.
Celgene Corporation
CONTACT: Robert J. Hugin, President and COO, +1-908-673-9102, or Brian P.Gill, Senior Director, PR and IR, +1-908-673-9530, both of CelgeneCorporation
Web site: http://www.celgene.com/
